Community-Engaged Research to Address Health Disparities in Systemic Lupus Erythematosus.
R Ezequiel BorgiaGraciela S AlarconPublished in: Arthritis care & research (2021)
Systemic lupus erythematosus (SLE) is a systemic autoimmune disease characterized by evidence of autoantibodies and multiorgan system involvement leading to significant physical and functional disability. The reported incidence and prevalence of SLE in the US vary by region but are estimated to be around 5.5 per 100,000 per year and 72.8 per 100,000 persons, respectively. Several social determinants of health including educational level, health insurance, household income, social support as well as environmental and occupational exposures may impact lupus outcomes.
Keyphrases
- systemic lupus erythematosus
- mental health
- health insurance
- social support
- disease activity
- healthcare
- affordable care act
- public health
- depressive symptoms
- risk factors
- multiple sclerosis
- physical activity
- human health
- health information
- air pollution
- metabolic syndrome
- risk assessment
- rheumatoid arthritis
- type diabetes
- skeletal muscle
- weight loss
- insulin resistance